RenaissanceRe: I'm Taking Advantage Of 7.38% Yielding Preferred Stock

Blue Bird: The Profit Test Behind Its Next Growth Cycle

Collegium Pharmaceutical: Under 3x Cash Earnings After A Narrow Guidance Cut

Step Back: The Leadership Lesson High Achievers Often Miss

Sometimes the best way to lead is to get out of the way.